Thyroid function in affective disorders and alcoholism

The effect of feeding on cerebrospinal fluid corticotropin-releasing hormone levels in humans.

Brain research·2001

Serum thyrotropin concentrations and bioactivity during sleep deprivation in depression.

Archives of general psychiatry·2001

Intra- and inter-individual correlations between cholecystokinin and corticotropin-releasing hormone concentrations in human cerebrospinal fluid.

Depression and anxiety·1999

Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.

Biological psychiatry·1997

Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling.

Depression and anxiety·1997

Individual differences in repressive-defensiveness predict basal salivary cortisol levels.

Journal of personality and social psychology·1996

The Horizon Ahead: Emerging Adjunctive Therapies for Type 1 Diabetes.

Endocrinology and metabolism clinics of North America·2026

Expectations and Experiences: What People with Type 1 Diabetes Really Want from Adjunctive Therapies.

Endocrinology and metabolism clinics of North America·2026

Combination of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter Inhibitors in Type 1 Diabetes: Why, when and How? An Exploration of the Rationale and Clinical Scenarios for Combining These 2 Adjunctive Agents.

Endocrinology and metabolism clinics of North America·2026

Clinical Guidance on the Safe Use of Sodium-Glucose Cotransporter Inhibitors in Adults with Type 1 Diabetes.

Endocrinology and metabolism clinics of North America·2026

Clinical Guidance on the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in Adults with Type 1 Diabetes.

Endocrinology and metabolism clinics of North America·2026

Future of Continuous Ketone Monitoring and Its Utility for Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes.

Endocrinology and metabolism clinics of North America·2026

A Rat Excisional Wound Model for Investigating Therapeutics in Critical-Size Skin Wounds.

Journal of visualized experiments : JoVE·2026

Current evidence across the treatment spectrum of adrenocortical carcinoma: a comprehensive scoping review.

Endocrine oncology (Bristol, England)·2026

Combination of Palladium Nanoparticles and Tubastatin-A Potentiates Apoptosis in Human Breast Cancer Cells: A Novel Therapeutic Approach for Cancer [Retraction].

International journal of nanomedicine·2026

Different Acupuncture Therapies for Postoperative Residual Pain Following PKP/PVP for Osteoporotic Vertebral Compression Fractures: A Protocol for a Systematic Review and Bayesian Network Meta-Analysis.

Journal of pain research·2026

Comparison of Remimazolam and Propofol for Anesthesia Management in Liver Cancer Patients Undergoing Percutaneous Radiofrequency Ablation: A Randomized Controlled Trial.

Drug design, development and therapy·2026

Testosterone dynamics and oncologic safety in biochemically recurrent prostate cancer: An analysis of intermittent androgen deprivation therapy schedules.

Prostate international·2026

Related Experiment Videos

Thyroid function in affective disorders and alcoholism

Related Concept Videos

The effect of feeding on cerebrospinal fluid corticotropin-releasing hormone levels in humans.

Serum thyrotropin concentrations and bioactivity during sleep deprivation in depression.

Intra- and inter-individual correlations between cholecystokinin and corticotropin-releasing hormone concentrations in human cerebrospinal fluid.

Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.

Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling.

Individual differences in repressive-defensiveness predict basal salivary cortisol levels.

The Horizon Ahead: Emerging Adjunctive Therapies for Type 1 Diabetes.

Expectations and Experiences: What People with Type 1 Diabetes Really Want from Adjunctive Therapies.

Combination of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter Inhibitors in Type 1 Diabetes: Why, when and How? An Exploration of the Rationale and Clinical Scenarios for Combining These 2 Adjunctive Agents.

Clinical Guidance on the Safe Use of Sodium-Glucose Cotransporter Inhibitors in Adults with Type 1 Diabetes.

Clinical Guidance on the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in Adults with Type 1 Diabetes.

Future of Continuous Ketone Monitoring and Its Utility for Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes.

A Rat Excisional Wound Model for Investigating Therapeutics in Critical-Size Skin Wounds.

Current evidence across the treatment spectrum of adrenocortical carcinoma: a comprehensive scoping review.

Combination of Palladium Nanoparticles and Tubastatin-A Potentiates Apoptosis in Human Breast Cancer Cells: A Novel Therapeutic Approach for Cancer [Retraction].

Different Acupuncture Therapies for Postoperative Residual Pain Following PKP/PVP for Osteoporotic Vertebral Compression Fractures: A Protocol for a Systematic Review and Bayesian Network Meta-Analysis.

Comparison of Remimazolam and Propofol for Anesthesia Management in Liver Cancer Patients Undergoing Percutaneous Radiofrequency Ablation: A Randomized Controlled Trial.

Testosterone dynamics and oncologic safety in biochemically recurrent prostate cancer: An analysis of intermittent androgen deprivation therapy schedules.

Related Experiment Videos

Thyroid function in affective disorders and alcoholism

Abstract:

Related Concept Videos

Related Articles